EGRP-Supported Epidemiology Consortia
| Title of Initiative | NIH Contacts | Lead Contacts/Principal Investigators | EGRP-Funded Grant (if appropriate) | Consortia Type | Year EGRP Facilitation and/or Funding Began |
|---|---|---|---|---|---|
| Esophageal Adenocarcinoma and Barrett’s Esophagus Consortium (BEACON) | EGRP/NCI: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov DCEG/NCI: |
Lead Contact/PI: Includes various EGRP-supported investigators teamed with DCEG investigators. One contact: Thomas Vaughn, Ph.D., M.H.S.A. thomas-vaughn@uiowa.edu |
Case-control | ||
| Amitabh Chak, M.D. Case Western Reserve University axc22@case.edu |
Insulin/IGF-1 Pathway in Barrett's Esophagus, R21CA135692 |
| Key to Acronyms Used in Tables | |
|---|---|
| EGRP | Epidemiology and Genetics Research Program |
| CDC | Centers for Disease Control and Prevention |
| DCB | Division of Cancer Biology |
| DCEG | Division of Cancer Epidemiology and Genetics |
| NCI | National Cancer Institute |
| NHGRI | National Human Genome Research Institute |
| NIEHS | National Institute of Environmental Health Sciences |
| NIH | National Institutes of Health |
| OCS | Office of Cancer Survivorship |
| OD | Office of the Director |